Search Results 211-220 of 16898 for Amphotericin B

  1. Collaborators - Gut Microbiome Laboratory - Mayo Clinic Research

    External collaborators. Eugene B. Chang, M.D.. University of Chicago Chicago, Illinois; Jeremiah Faith, Ph.D. Mount Sinai

  2. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  3. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research

    b · Barrett, Michael T. Ph.D. Barrett.Michael@mayo.edu · Publications · Behfar, Atta M.D., Ph.D. behfar.atta@mayo.edu; Professor of Medicine; Assistant ...

  4. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Displaying 1-2 out of 2 doctors available. Last Name Initial: O. Ciara O ...

  6. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    Displaying 1-10 out of 14 doctors available. Last Name Initial: B. Dilhana S. Badurdeen, ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    active List of physicians whose last names begin with B B · List of physicians whose last names begin with C C · List of physicians whose last names begin with ...

  9. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  10. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second ...